PPD Clinical Research Associates Honored for Excellence in Global Competitions

WILMINGTON, N.C.--()--Pharmaceutical Product Development, LLC (PPD) won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions, with 16 PPD clinical research professionals recognized by industry peers for their expertise in the enterprise of drug development.

PPD clinical researchers won two gold, four silver and three bronze awards at the PharmaTimes Clinical Researcher of the Year – International competition finale in London. They were recognized in categories including Aspiring Clinical Researcher, Clinical Research Associate, In-House Clinical Researcher and Clinical Research Team. At the PharmaTimes Clinical Researcher of the Year – The Americas competition finale in Boston, a PPD clinical research associate (CRA) earned silver in the Experienced CRA category.

“PPD’s clinical researchers embody the utmost expertise and professionalism to achieve this industry recognition,” said Roger Newbery, senior vice president of integrated monitoring and investigator services for PPD. “We congratulate them on this honor and appreciate the talent, success and dedication our clinical researchers bring to all of our clients and their research programs.”

PPD prepares CRAs for success with its acclaimed Clinical Foundation Program and PPD’s CRA Academy, which reflect the company’s strategic emphasis on recruiting, training and retaining industry-leading talent for customers’ important research programs. PPD’s award-winning programs for employee development have earned it recognition for eight consecutive years on Training magazine’s Training Top 125 list of companies excelling in employee learning and development. PPD has been named for two consecutive years to Forbes magazine’s list of America’s Best Large Employers.

The PharmaTimes competition was created in 1999 to provide clinical research professionals with the opportunity to benchmark their professional skills against their peers in a program of competency-based exercises developed through cross-industry collaboration. Both competitions featured a demanding, yearlong, three-part series of tests, including real-life challenges judged by industry leaders.

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 21,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppdi.com.

Contacts

Media:
Holly Devine
+1 919 456 6389
holly.devine@ppdi.com

Investors:
Nate Speicher
+1 910 558 6783
nate.speicher@ppdi.com

Contacts

Media:
Holly Devine
+1 919 456 6389
holly.devine@ppdi.com

Investors:
Nate Speicher
+1 910 558 6783
nate.speicher@ppdi.com